Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Similar articles for PubMed (Select 20187100)

1.

Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis.

Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN.

Cancer. 2010 May 1;116(9):2234-41. doi: 10.1002/cncr.24966.

2.

Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database.

Rueth NM, Groth SS, Tuttle TM, Virnig BA, Al-Refaie WB, Habermann EB.

Ann Surg Oncol. 2010 Jun;17(6):1662-8. doi: 10.1245/s10434-010-0965-8. Epub 2010 Feb 18.

PMID:
20165985
3.

Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease.

Bowles TL, Xing Y, Hu CY, Mungovan KS, Askew RL, Chang GJ, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN.

Ann Surg Oncol. 2010 Aug;17(8):2015-23. doi: 10.1245/s10434-010-1051-y. Epub 2010 Apr 6.

PMID:
20369298
4.

An individualized conditional survival calculator for patients with rectal cancer.

Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ.

Dis Colon Rectum. 2013 May;56(5):551-9. doi: 10.1097/DCR.0b013e31827bd287.

5.

Practical application of a calculator for conditional survival in colon cancer.

Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA.

J Clin Oncol. 2009 Dec 10;27(35):5938-43. doi: 10.1200/JCO.2009.23.1860. Epub 2009 Oct 5.

6.

Melanoma survival in the United States, 1992 to 2005.

Pollack LA, Li J, Berkowitz Z, Weir HK, Wu XC, Ajani UA, Ekwueme DU, Li C, Pollack BP.

J Am Acad Dermatol. 2011 Nov;65(5 Suppl 1):S78-86. doi: 10.1016/j.jaad.2011.05.030.

7.

Is sex an independent prognostic factor in cutaneous head and neck melanoma?

Arce PM, Camilon PR, Stokes WA, Nguyen SA, Lentsch EJ.

Laryngoscope. 2014 Jun;124(6):1363-7. doi: 10.1002/lary.24439. Epub 2013 Nov 7.

PMID:
24122966
8.

Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.

Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE.

Arch Dermatol. 2008 Apr;144(4):515-21. doi: 10.1001/archderm.144.4.515.

PMID:
18427046
9.

Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001.

Choi M, Fuller CD, Thomas CR Jr, Wang SJ.

Gynecol Oncol. 2008 May;109(2):203-9. doi: 10.1016/j.ygyno.2008.01.033. Epub 2008 Mar 7.

PMID:
18329082
10.

Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.

Green AC, Baade P, Coory M, Aitken JF, Smithers M.

J Clin Oncol. 2012 May 1;30(13):1462-7. doi: 10.1200/JCO.2011.38.8561. Epub 2012 Mar 12.

11.

Marital status independently predicts testis cancer survival--an analysis of the SEER database.

Abern MR, Dude AM, Coogan CL.

Urol Oncol. 2012 Jul-Aug;30(4):487-93. doi: 10.1016/j.urolonc.2010.03.005. Epub 2010 Sep 26.

PMID:
20870430
12.

Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.

Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC.

Cancer. 1999 Dec 1;86(11):2252-8.

PMID:
10590365
13.

Ultrathin primary is a marker for worse prognosis in lymph node-positive cutaneous melanoma.

Bagaria SP, Ray PS, Joseph RW, Heckman MG, Rawal B, Gray RJ, Pockaj B, Wasif N.

Cancer. 2013 May 15;119(10):1860-7. doi: 10.1002/cncr.27985. Epub 2013 Feb 13.

14.

Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.

Harcharik S, Bernardo S, Moskalenko M, Pan M, Sivendran M, Bell H, Hall LD, Castillo-Martín M, Fox K, Cordon-Cardo C, Chang R, Sivendran S, Phelps RG, Saenger Y.

J Am Acad Dermatol. 2014 Jun;70(6):1036-44. doi: 10.1016/j.jaad.2014.01.914. Epub 2014 Mar 31.

PMID:
24698703
15.

Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, et al.

Cancer. 1995 May 15;75(10):2484-91.

PMID:
7736392
16.

A population-based validation of the American Joint Committee on Cancer melanoma staging system.

Gimotty PA, Botbyl J, Soong SJ, Guerry D.

J Clin Oncol. 2005 Nov 1;23(31):8065-75.

17.

Age and gender are significant independent predictors of survival in primary cutaneous melanoma.

Lasithiotakis K, Leiter U, Meier F, Eigentler T, Metzler G, Moehrle M, Breuninger H, Garbe C.

Cancer. 2008 Apr 15;112(8):1795-804. doi: 10.1002/cncr.23359.

19.

Clinicopathologic analysis of malignant melanoma in Taiwan.

Chen YJ, Wu CY, Chen JT, Shen JL, Chen CC, Wang HC.

J Am Acad Dermatol. 1999 Dec;41(6):945-9.

PMID:
10570378
20.

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.

Zörnig I, Halama N, Lorenzo Bermejo J, Ziegelmeier C, Dickes E, Migdoll A, Kaiser I, Waterboer T, Pawlita M, Grabe N, Ugurel S, Schadendorf D, Falk C, Eichmüller SB, Jäger D.

Int J Cancer. 2015 Jan 1;136(1):138-51. doi: 10.1002/ijc.28980. Epub 2014 May 28.

PMID:
24839182
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk